AMBER WHITLATCH: Open Payments
NPI 1891406401 · MAINEVILLE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$522 in 24 payments from 9 companies in 2025. Trend: 2023 $741 · 2024 $918 · 2025 $522
Food & beverage: $522
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 3 | $162 |
| Otsuka America Pharmaceutical, Inc. | 5 | $80 |
| Noven Therapeutics, LLC | 4 | $65 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $46 |
| Alkermes, Inc. | 3 | $46 |
| Supernus Pharmaceuticals, Inc. | 2 | $43 |
| Lundbeck LLC | 2 | $34 |
| Teva Pharmaceuticals USA, Inc. | 1 | $26 |
| ABBVIE INC. | 1 | $20 |
Products named: Auvelity, REXULTI, Xelstrym, TRINTELLIX, ARISTADA, Qelbree, ABILIFY MAINTENA, AUSTEDO XR.
Industry payments across OH — which companies pay providers there.
